(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

The chiral title compound, C(16)H(20)N(2)O(2), which can be used for producing active pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and other pathologies dependent on insulin resistance, was prepared from (1R,3S)-camphoric acid and o-phenyl­enedi­amine. It crystallized from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovalenko, Sergiy M., Konovalova, Irina S., Merzlikin, Sergiy I., Chuev, Vladimir P., Kravchenko, Dmitry V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2020
Materias:
Research Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472757/
https://www.ncbi.nlm.nih.gov/pubmed/32939290
http://dx.doi.org/10.1107/S2056989020010439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472757/
https://www.ncbi.nlm.nih.gov/pubmed/32939290
http://dx.doi.org/10.1107/S2056989020010439

Ejemplares similares